Search for: "ALZA Corporation"
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Personnel
[Inspire Pharmaceuticals]
|
Darl Moreland Joins Alexza Pharmaceuticals as Vice President, Quality
HSMN NewsFeed,
12 Aug 2010:
Biopharmaceuticals, Personnel
[Alexza Pharmaceuticals]
|
BIND Biosciences Appoints Ed Schnipper, M.D., as Chief Medical Officer
HSMN NewsFeed,
29 Jun 2010:
Biopharmaceuticals, Personnel
[BIND Biosciences, Nanoengineering]
|
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
HSMN NewsFeed,
3 May 2010:
Biopharmaceuticals, Personnel
[VIVUS]
|
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
HSMN NewsFeed,
2 Mar 2010:
Biopharmaceuticals, FDA
[Covidien, EXALGO, hydromorphone]
|
NeurogesX Announces Management Team Promotions
HSMN NewsFeed,
4 Feb 2010:
Biopharmaceuticals, Personnel
[NeurogesX]
|
AcelRx Pharmaceuticals Hires Nigel Ray as Vice President of Business Development
HSMN NewsFeed,
14 Oct 2009:
Biopharmaceuticals, Personnel
[AcelRx Pharmaceuticals]
|
Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt
HSMN NewsFeed,
17 Jun 2009:
Biopharmaceuticals
[Neuromed Pharmaceuticals, Exalgo, hydromorphone, Covidien, Mallinckrodt]
|
Jazz Pharmaceuticals, Inc. Announces Board of Directors and Management Changes
HSMN NewsFeed,
2 Apr 2009:
Biopharmaceuticals, Personnel
[Jazz Pharmaceuticals]
|
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
HSMN NewsFeed,
30 Mar 2009:
Biopharmaceuticals, Neurology, Personnel
[BrainCells]
|
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
HSMN NewsFeed,
23 Mar 2009:
Biopharmaceuticals, Pain Management
[Neuromed Pharmaceuticals, Exalgo, hydromorphone, NMED-1077]
|
AcelRx Pharmaceuticals Hires Mark Evashenk as Vice President of Clinical Operations
HSMN NewsFeed,
6 Mar 2009:
Biopharmaceuticals, Personnel
[AcelRx Pharmaceuticals]
|
Hana Biosciences Appoints Thomas J. Tarlow as Vice President, Regulatory Affairs and Quality
HSMN NewsFeed,
12 Jan 2009:
Biopharmaceuticals, Personnel
[Hana Biosciences]
|
AcelRx Pharmaceuticals Hires Roman Skowronski, M.D., Ph.D. as Vice President of Clinical Development
HSMN NewsFeed,
8 Jan 2009:
Biopharmaceuticals, Personnel
[AcelRx Pharmaceuticals]
|
PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
HSMN NewsFeed,
31 Dec 2008:
Biopharmaceuticals, Drug Delivery, Product Recall
[PriCara, Ortho-McNeil-Janssen Pharmaceuticals, DURAGESIC, fentanyl transdermal]
|
Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Personnel
[Molecular Insight Pharmaceuticals]
|
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
HSMN NewsFeed,
8 Sep 2008:
Biopharmaceuticals, Personnel
[Zosano Pharma]
|
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
HSMN NewsFeed,
5 Sep 2008:
Biopharmaceuticals, Personnel
[Questcor Pharmaceuticals]
|
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
HSMN NewsFeed,
3 Sep 2008:
Biopharmaceuticals, Venture Capital
[Osprey Pharmaceuticals]
|
Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
HSMN NewsFeed,
9 Jul 2008:
Biopharmaceuticals, Personnel
[Alexza Pharmaceuticals]
|
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
HSMN NewsFeed,
8 Jul 2008:
Biopharmaceuticals
[Novartis, Focalin XR, Focalin, ADHD, dexmethylphenidate]
|
Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
HSMN NewsFeed,
3 Jun 2008:
Biopharmaceuticals, Personnel
[Sunesis Pharmaceuticals]
|
Neuromed Names Sean Cunliffe Chief Commercial Officer
HSMN NewsFeed,
29 Apr 2008:
Biopharmaceuticals, Personnel
[Neuromed Pharmaceuticals]
|
IMPAX Establishes Branded Products Division with Appointments of Senior Management
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals, Personnel
[IMPAX Laboratories, IMPAX Pharmaceuticals]
|
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
HSMN NewsFeed,
27 Nov 2007:
Biopharmaceuticals, Personnel
[Neuromed Pharmaceuticals]
|
New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
HSMN NewsFeed,
26 Oct 2007:
Biopharmaceuticals
[McNeil Pediatrics, ALZA Corporation, CONCERTA, methylphenidate, ADHD]
|
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
HSMN NewsFeed,
15 Oct 2007:
Biopharmaceuticals, Pain Mangement, FDA
[Neuromed Pharmaceuticals, NMED-1077, OROS , Hydromorphone]
|
NeurogesX Expands Senior Management Team
HSMN NewsFeed,
9 Oct 2007:
Biopharmaceuticals, Personnel
[NeurogesX]
|
Celgene Corporation Elects Ernest Mario to Board of Directors
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Personnel
[Celgene]
|
Watson Receives FDA Approval For Generic Duragesic(R)
HSMN NewsFeed,
21 Aug 2007:
Biopharmaceuticals, FDA, Generics, Drug Delivery
[Watson Pharmaceuticals, fentanyl transdermal system, ALZA , Duragesic]
|
Neuromed Raises US$53.3 Million in Series E Financing to Accelerate Development of Pain Treatments
HSMN NewsFeed,
21 Aug 2007:
Biopharmaceuticals, Venture Capital
[Neuromed Pharmaceuticals]
|
Semafore Pharmaceuticals Names Veteran Life Sciences Executive Edward L. Jacobs as Chief Executive Officer
HSMN NewsFeed,
3 Aug 2007:
Biopharmaceuticals, Personnel
[Semafore Pharmaceuticals]
|
Neuromed Appoints Mario Orlando as Vice President of Marketing
HSMN NewsFeed,
2 Aug 2007:
Biopharmaceuticals, Personnel
[Neuromed Pharmaceuticals]
|
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Drug Delivery, Regulatory
[Janssen, INVEGA, paliperidone, osmotic delivery, schizophrenia]
|
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Personnel
[Avid Radiopharmaceuticals]
|
Intradigm Announces Addition of Samuel Zalipsky to Management Team
HSMN NewsFeed,
30 May 2007:
Biopharmaceuticals, Personnel
[Intradigm]
|
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
HSMN NewsFeed,
27 Apr 2007:
Biopharmaceuticals, Regulatory
[Janssen-Cilag, INVEGA , paliperidone, schizophrenia]
|
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
HSMN NewsFeed,
24 Apr 2007:
Biopharmaceuticals, Drug Delivery, Licensing
[Neuromed Technologies, ALZA Corp, OROS , Hydromorphone]
|
Sunesis Pharmaceuticals Appoints Valerie L. Pierce Senior Vice President, General Counsel and Corporate Secretary
HSMN NewsFeed,
17 Apr 2007:
Biopharmaceuticals, Personnel
[Sunesis Pharmaceuticals]
|
Threshold Pharmaceuticals Appoints David R. Hoffmann to Board of Directors
HSMN NewsFeed,
4 Apr 2007:
Biopharmaceuticals, Personnel
[Threshold Pharmaceuticals]
|
Catalyst Appoints Erik Wiberg Chief Financial Officer
HSMN NewsFeed,
1 Feb 2007:
Biopharmaceuticals, Personnel
[Catalyst Biosciences]
|
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
HSMN NewsFeed,
31 Jan 2007:
Biopharmaceuticals, Drug Delivery, Generics, FDA
[Mylan Laboratories, Fentanyl Transdermal System, Alza , Duragesic]
|
Capnia Announces Appointment of Joseph J. Vallner as President and CEO
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals, Personnel
[Capnia]
|
INVEGA(TM) Approved By FDA as New Treatment for Schizophrenia
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals, FDA
[Janssen, J&JPRD, INVEGA , paliperidone, schizophrenia]
|
Cara Therapeutics Secures $19 Million in Series C Financing
HSMN NewsFeed,
28 Nov 2006:
Biopharmaceuticals, Venture Capital
[Cara Therapeutics]
|
Janssen, L.P. Selects INVEGA(TM) (paliperidone) Extended Release tablets as Brand Name for Its Investigational Atypical Antipsychotic
HSMN NewsFeed,
10 Nov 2006:
Biopharmaceuticals
[Janssen, INVEGA , paliperidone, schizophrenia]
|
Mylan Receives Final FDA Approval for Oxybutynin Chloride Extended-release Tablets
HSMN NewsFeed,
10 Nov 2006:
Biopharmaceuticals, Generics, FDA
[Mylan Laboratories, Mylan Pharmaceuticals, Oxybutynin, Alza , Ditropan XL]
|
IMPAX Announces Dismissal of Lawsuit Related to Generic Concerta(R)
HSMN NewsFeed,
3 Oct 2006:
Biopharmaceuticals, Generics, Litigation
[IMPAX Laboratories, ALZA Corporation, McNeil-PPC, methylphenidate, Concerta]
|
FDA Issues Approvable Letter for Paliperidone ER for the Treatment of Schizophrenia
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals, FDA
[Johnson & Johnson, paliperidone, schizophrenia]
|
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
HSMN NewsFeed,
28 Sep 2006:
Biopharmaceuticals, Personnel
[Cerimon Pharmaceuticals]
|
U.S. Court of Appeals Rules in Favor of Mylan in Oxybutynin Patent Litigation
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Generics, Litigation
[Mylan Laboratories, Oxybutynin, DITROPAN XL]
|
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Generics, Litigation
[IMPAX Laboratories, Alza , Ditropan XL, Oxybutynin]
|
Corgentech Announces Appointment of K. Peony Yu as Vice President, Clinical Research and Michael Leong as Director, Clinical Research
HSMN NewsFeed,
6 Jun 2006:
Biopharmaceuticals, Personnel
[Corgentech]
|
New Data Show Overactive Bladder Therapy Enablex(R) Does Not Impair Memory Function Compared to Frequently Used Alternative
HSMN NewsFeed,
23 May 2006:
Biopharmaceuticals, Urology, Neurology
[Novartis, Enablex, darifenacin, overactive bladder, Ditropan, oxybutynin]
|
ALZA Corporation Receives FDA Approval for IONSYS(TM) (Fentanyl Iontophoretic Transdermal System)
HSMN NewsFeed,
23 May 2006:
Biopharmaceuticals, Drug Delivery, FDA
[ALZA , IONSYS , E-TRANS , iontophoresis]
|
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
HSMN NewsFeed,
11 May 2006:
Biopharmaceuticals, Personnel
[Genentech]
|
Avigen Announces Management Changes
HSMN NewsFeed,
27 Mar 2006:
Biopharmaceuticals, Personnel
[Avigen]
|
European Commission Approves IONSYS(TM) (Fentanyl HCl Iontophoretic Transdermal System)
HSMN NewsFeed,
30 Jan 2006:
Biopharmaceuticals, Drug Delivery, Regulatory
[ALZA Corp, IONSYS, Fentanyl, transdermal]
|
DURECT Announces Promotions and Management Changes
HSMN NewsFeed,
6 Jan 2006:
Biopharmaceuticals, Personnel
[DURECT]
|
Cara Therapeutics Announces Global Licensing Deal of Novel Pain Drug Candidate With ALZA Corporation
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals, Licensing
[Cara Therapeutics, ALZA Corporation, Johnson & Johnson, CR665]
|
Affymax Appoints Paul B. Cleveland as Chief Financial Officer and Executive Vice President of Corporate Development
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals, Personnel
[Affymax]
|
Ilypsa Announces Appointment of Jay P. Shepard as President and CEO
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals, Personnel
[Ilypsa]
|
NeurogesX Appoints Jeffrey Tobias, M.D., as Chief Medical Officer
HSMN NewsFeed,
3 Jan 2006:
Biopharmaceuticals, Personnel
[NeurogesX]
|
|
|
Public
Feeds 
Full text >>
